Mónica et al found that lipoprotein‐based nanostructures realize efficient GIC accumulation and therapeutic effects through CXCR4 receptor‐stimulated macropinocytosis, providing a powerful nanoplatform for RNA interference drugs targeting Notch1 to combat glioma.16 This evidence concerns the gene NOTCH1 and central nervous system cancer.